“The IDEAL Trial - a Study Protocol for a Phase III Randomized, Double-Blinded Clinical Trial Assessing the Ultra-Short Antibiotic Prophylaxis of Isoniazid and Rifapentine in Non-Immunosuppressed Patients With Newly Diagnosed Latent Tuberculosis”. Principles and Practice of Clinical Research 6, no. 1 (May 21, 2020): 9–14. Accessed May 7, 2024. https://journal.ppcr.org/index.php/ppcrjournal/article/view/96.